Novel Patched 1 Mutations in Patients with Gorlin-Goltz Syndrome Strategic Treated by Smoothened Inhibitor
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We studied a family with Gorlin-Goltz syndrome. The novel mutations of our cases were located on the 21st exon of the PTCH1 gene (c.3450C>G). The father, who received a strategic 56-day vismodegib treatment for disease control, was the first patient with Gorlin syndrome treated with the hedgehog inhibitor in Taiwan. The lesions regressed gradually, with scar formation, and were subsequently removed via a wide excision. Further details are provided below.
Abstract
We studied a family with Gorlin-Goltz syndrome. The novel mutations of our cases were located on the 21st exon of the PTCH1 gene (c.3450C>G). The father, who received a strategic 56-day vismodegib treatment for disease control, was the first patient with Gorlin syndrome treated with the hedgehog inhibitor in Taiwan. The lesions regressed gradually, with scar formation, and were subsequently removed via a wide excision. Further details are provided below.
참고문헌 (13)
- Gorlin RJ, "Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome", N Engl J Med, 262, pp.908~912 (1960)[DOI]
- Farndon PA, "Location of gene for Gorlin syndrome", Lancet, 339, pp.581~582 (1992)[DOI]
- Hahn H, "Mutations of the human homolog of drosophila patched in the nevoid basal cell carcinoma syndrome", Cell, 85, pp.841~851 (1996)[DOI]
- Smyth I, "Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32", Hum Mol Genet, 8, pp.291~297 (1999)[DOI]
- Pastorino L, "Identification of a SUFU germline mutation in a family with Gorlin syndrome", Am J Med Genet A, 149A, pp.1539~1543 (2009)[DOI]
- Jacobsen AA, "Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies", JAMA Dermatol, 152, pp.816~824 (2016)[DOI]
- Boutet N, "Spectrum of PTCH1 mutations in French patients with Gorlin syndrome", J Invest Dermatol, 121, pp.478~481 (2003)[DOI]
- Smith MJ, "Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations", J Clin Oncol, 32, pp.4155~4161 (2014)[DOI]
- Jayaraman SS, "Mutational landscape of basal cell carcinomas by wholeexome sequencing", J Invest Dermatol, 134, pp.213~220 (2014)[DOI]
- Tang JY, "Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome", N Engl J Med, 366, pp.2180~2188 (2012)[DOI]
- Yang X, "Intermittent vismodegib therapy in basal cell nevus syndrome", JAMA Dermatol, 152, pp.223~224 (2016)[DOI]
- Dreno B, "Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial", Lancet Oncol, 18, pp.404~412 (2017)[DOI]
- Jacobsen AA, "Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies", JAMA Dermatol, 152, pp.816~824 (2016)[DOI]
